Regulatory Th2-type T cell lines against insulin and gad peptides derived from orally- and nasally-treated NOD mice suppress diabetes

Journal of Autoimmunity

Volumn 12, Issue 4, 1999, Pages 251-258

  Maron, Ruth ^a   Melican, Nancy S ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diabetes; GAD; Insulin; Nasal tolerance; Oral tolerance; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; INSULIN TOLERANCE TEST; INTERFERON PRODUCTION; INTRANASAL DRUG ADMINISTRATION; LYMPH NODE; LYMPHOCYTE TRANSFER; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0033055884     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0278     Document Type: Article

References (45)

1. Castano L., Eisenbarth G.S. Type-1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8:1990;647-679.
2. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 15:1994;516-542.
3. Leiter E.H., Serreze D.V., Prochaz K.A.M. The epidemiology of diabetes in NOD mice. Immunol. Today. 11:1990;147-149.
4. Haskins K., Wegmann D. Diabetogenic T-cell clones. Diabetes. 45:1996;1299-1305.
5. Mori Y., Suko M., Okudiara H., Matsuba I., Tsurvoka S., Sasaki A., Yokoyama H., Tanase T., Shida T., Nishimura M., Terada E., Ikeda Y. Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia. 29:1986;244-247.
6. Ogawa M., Maruyama T., Hasegawa T., Kanaya T., Kobayash F., Tochino Y., Uda H. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice. Biomed. Res. 1:1985;103-105.
7. Chen Y., Kuchroo V.K., Inobe J.I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
8. Zhang J.Z., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:1991;10252-10256.
9. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
10. Daynes R., Araneo B., Dowell T., Huang K., Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med. 171:1990;979-996.
11. Coffman R., Lebman D., Shrader B. Transforming growth factor beta (TGFβ) specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 144:1989;3411-3416.
12. Daniel D., Wegmann D.R. Protection of nonobese diabetic mice from diabetics by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA. 93:1996;956-960.
13. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1996;1561-1567.
14. +T cells in the pathogenesis of organspecific atuoimmune disease. Immunol. Today. 16:1995;34-38.
15. Kaufman D.I., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercaz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
16. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
17. Debray-Sachs M., Carnaud C., Boitard H., Cohen I., Gresser P., Bedossa P., Bach J.-F. Prevention of diabetes in NOD mice treated with antibody to murine INF-γ J. Autoimmun. 4:1991;237-248.
18. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:1993;87-99.
19. Shehadeh N., LaRosa F., Lafferty K. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
20. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 7:1997;727-738.
21. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Poscelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., Halfer D.A. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:1998;177-181.
22. Pakala S.V., Kurrer M.O., Katz J.D. T helper (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:1997;299-306.
23. Katz J., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
24. Ploix C., Bergerot I., Fabien N., Moulin V., Thivolet C. Protection against autoimmune diabetes with oral insulin is associated with the homing of IL-4 T helper type 2 cells to the pancreas and pancreatic lymph nodes. Diabetes. 47:1998;39-44.
25. Inobe J., Slavin A., Komagata Y., Chen Y., Liu L., Weiner H.L. IL-4 is a differentiation factor for TGF-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:1998;2780-2790.
26. +T cells: IL-4 and IFN-γhave opposing effects, while TGF-βpositively regulates its own production. J. Immunol. 160:1998;5719-5728.
27. Hancock W.W., Polanski M., Zhang Z.J., Blogg N., Weiner H.L. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-βand prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
28. +T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7:1994;655-663.
29. King C., Davies J., Mueller R., Lee M.S., Krahl T., Yeung B., O'Connor E., Sarvetnick N. TGF-betal alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity. 8:1998;601-613.
30. Mueller R., Krahl T., Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1996;1093-1099.
31. Moritani M., Yoshimoto K., Wong S., Tanaka C., Yamaoka T., Sano T., Komagata Y., Miyazaki J., Kikutani H., Itakura M. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-B1. J. Clin. Invest. 102:1998;499-506.
32. Polanski M., Blogg N.S., Zhang J., Weiner H.L. Oral administration of the immunodominant B-chain of insulin suppresses diabetes in NOD mice and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10:1997;339-346.
33. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:1996;2167-2174.
34. Peterson J.D., Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes. 45:1996;328-336.
35. Miller A., Lider O., Weiner H.L. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 174:1991;791-798.
36. Harrison L.C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today. 13:1992;348-352.
37. von Herrath M.G., Dyrberg T., Oldstone M.B.A. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 98:1996;1324-1331.
38. Lenschow D., Herold K., Ree L., Patel B., Koons A., Singh B., Thompson C., Bluestone J. CD28/B7 regualtion of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:1996;285-293.
39. +Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101:1998;68-73.
40. Daniel D., Gill R., Schloot N.D.W. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1995;1056-1062.
41. +suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. J. Autoimmun. 10:1997;299-307.
42. +suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngenetic islet-transplanted NOD mice. J. Autoimmun. 9:1996;331-339.
43. Tisch R., Liblau R.S., Yang X.-D., Liblau P., McDevitt H.O. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes. 47:1998;894-899.
44. Dobbs, C. Pu, S.-F. Poulin, M. Haskins, K. 1998, Diabetogenic T Cells: Comparison of Pathogenic Properties of a Cloned T Cell Line and of T Cells from a TCR Transgenic Mouse, 3rd Immunology of Diabetes Society Conference, Oak Brook, Illinois.
45. Coutant R., Zeidler A., Rappaport R., Schatz D., Schwartz S., Raskin P., Rogers D., Bode B., Crockett S., Marks J., Deeb L., Chalew S., MacLaren N. Oral insulin therapy in newly-diagnosed immune mediated (type I) diabetes. Preliminary analysis of a randomized double blind placebo controlled study. Diabetes. 47:1998;A97.